Pfizer Beats the Street

After abandoning its bid for rival AstraZeneca, Pfizer posted higher-than-expected revenue boosted by cancer-drug demand. Merck Beats Forecasts
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.